OptiBiotix Health Plc (OPTI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, OptiBiotix Health Plc (OPTI) has a cash flow conversion efficiency ratio of -0.106x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-895.00K ≈ $-108.90 USD) by net assets (GBX8.42 Million ≈ $1.02K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See OPTI defensive interval ratio to measure how many days the company can operate on defensive assets alone.
OptiBiotix Health Plc - Cash Flow Conversion Efficiency Trend (2008–2024)
This chart illustrates how OptiBiotix Health Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
OptiBiotix Health Plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of OptiBiotix Health Plc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Thor Mining PLC
LSE:THR
|
-0.058x |
|
Sentia Asa
OL:SNTIA
|
-0.272x |
|
Nanoco Group plc
LSE:NANO
|
-0.051x |
|
Aeorema Communications Plc
LSE:AEO
|
1.017x |
|
Crimson Tide plc
LSE:TIDE
|
-0.014x |
|
The Siam Cement Public Company Limited
F:TCM1
|
0.018x |
|
Union Jack Oil plc
LSE:UJO
|
-0.037x |
|
Bay Capital PLC
LSE:BAY
|
-0.315x |
Annual Cash Flow Conversion Efficiency for OptiBiotix Health Plc (2008–2024)
The table below shows the annual cash flow conversion efficiency of OptiBiotix Health Plc from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see OptiBiotix Health Plc market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | GBX8.40 Million ≈ $1.02K |
GBX-1.77 Million ≈ $-215.11 |
-0.211x | -22.32% |
| 2023-12-31 | GBX8.87 Million ≈ $1.08K |
GBX-1.53 Million ≈ $-185.79 |
-0.172x | -69.24% |
| 2022-12-31 | GBX10.90 Million ≈ $1.33K |
GBX-1.11 Million ≈ $-134.93 |
-0.102x | -18.11% |
| 2021-12-31 | GBX18.17 Million ≈ $2.21K |
GBX-1.56 Million ≈ $-190.37 |
-0.086x | -9.96% |
| 2020-12-31 | GBX11.85 Million ≈ $1.44K |
GBX-927.96K ≈ $-112.91 |
-0.078x | +77.37% |
| 2019-12-31 | GBX4.98 Million ≈ $606.08 |
GBX-1.72 Million ≈ $-209.67 |
-0.346x | -98.06% |
| 2018-11-30 | GBX7.06 Million ≈ $859.29 |
GBX-1.23 Million ≈ $-150.09 |
-0.175x | +29.81% |
| 2017-11-30 | GBX7.05 Million ≈ $857.26 |
GBX-1.75 Million ≈ $-213.32 |
-0.249x | +0.09% |
| 2016-11-30 | GBX5.00 Million ≈ $608.74 |
GBX-1.25 Million ≈ $-151.61 |
-0.249x | +3.34% |
| 2015-11-30 | GBX3.82 Million ≈ $464.39 |
GBX-983.46K ≈ $-119.66 |
-0.258x | -69.62% |
| 2014-11-30 | GBX4.65 Million ≈ $565.66 |
GBX-706.24K ≈ $-85.93 |
-0.152x | +95.33% |
| 2013-11-30 | GBX115.88K ≈ $14.10 |
GBX-376.79K ≈ $-45.84 |
-3.251x | -33.04% |
| 2012-07-31 | GBX440.35K ≈ $53.58 |
GBX-1.08 Million ≈ $-130.94 |
-2.444x | -4398.03% |
| 2010-07-31 | GBX773.00K ≈ $94.05 |
GBX-42.00K ≈ $-5.11 |
-0.054x | +32.29% |
| 2009-07-31 | GBX810.00K ≈ $98.55 |
GBX-65.00K ≈ $-7.91 |
-0.080x | -145.20% |
| 2008-07-31 | GBX825.00K ≈ $100.38 |
GBX-27.00K ≈ $-3.29 |
-0.033x | -- |
About OptiBiotix Health Plc
OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology and derive potential… Read more